<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">JAMA Netw Open</journal-id><journal-id journal-id-type="iso-abbrev">JAMA Netw Open</journal-id><journal-title-group><journal-title>JAMA Network Open</journal-title></journal-title-group><issn pub-type="epub">2574-3805</issn><publisher><publisher-name>American Medical Association</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39729314</article-id><article-id pub-id-type="pmc">PMC11681381</article-id>
<article-id pub-id-type="doi">10.1001/jamanetworkopen.2024.52667</article-id><article-id pub-id-type="publisher-id">zoi241467</article-id><article-categories><subj-group subj-group-type="category" specific-use="electronic"><subject>Research</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Investigation</subject></subj-group><subj-group subj-group-type="online-only"><subject>Online Only</subject></subj-group><subj-group subj-group-type="subject-area"><subject>Oncology</subject></subj-group></article-categories><title-group><article-title>Radiologist Involvement in Radiation Oncology Peer Review</article-title><subtitle>A Systematic Review and Meta-Analysis</subtitle><alt-title alt-title-type="headline">Radiologist Involvement in Radiation Oncology Peer Review</alt-title><alt-title alt-title-type="running-head">Radiologist Involvement in Radiation Oncology Peer Review</alt-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Hughes</surname><given-names>Ryan T.</given-names></name><degrees>MD</degrees><xref rid="zoi241467aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Razavian</surname><given-names>Niema B.</given-names></name><degrees>MD</degrees><xref rid="zoi241467aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Smith</surname><given-names>Sydney</given-names></name><degrees>MSPH</degrees><xref rid="zoi241467aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>D&#x02019;Agostino</surname><given-names>Ralph B.</given-names><suffix>Jr</suffix></name><degrees>PhD</degrees><xref rid="zoi241467aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Bunch</surname><given-names>Paul M.</given-names></name><degrees>MD</degrees><xref rid="zoi241467aff3" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Ponnatapura</surname><given-names>Janardhana</given-names></name><degrees>MD</degrees><xref rid="zoi241467aff3" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Royce</surname><given-names>Trevor J.</given-names></name><degrees>MD</degrees><degrees>MS</degrees><degrees>MSPH</degrees><xref rid="zoi241467aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Ververs</surname><given-names>James D.</given-names></name><degrees>PhD</degrees><xref rid="zoi241467aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Nightingale</surname><given-names>Chandylen L.</given-names></name><degrees>PhD</degrees><xref rid="zoi241467aff4" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Weaver</surname><given-names>Kathryn E.</given-names></name><degrees>PhD</degrees><xref rid="zoi241467aff4" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Farris</surname><given-names>Michael K.</given-names></name><degrees>MD</degrees><xref rid="zoi241467aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="zoi241467aff1"><label>1</label>Department of Radiation Oncology, Wake Forest University School of Medicine, Winston-Salem, North Carolina</aff><aff id="zoi241467aff2"><label>2</label>Department of Biostatistics and Data Science, Wake Forest University School of Medicine, Winston-Salem, North Carolina</aff><aff id="zoi241467aff3"><label>3</label>Department of Radiology, Wake Forest University School of Medicine, Winston-Salem, North Carolina</aff><aff id="zoi241467aff4"><label>4</label>Department of Social Sciences and Health Policy, Wake Forest University School of Medicine, Winston-Salem, North Carolina</aff><author-notes><title>Article Information</title><p><bold>Accepted for Publication:</bold> October 28, 2024.</p><p content-type="published-online"><bold>Published:</bold> December 27, 2024. doi:<uri content-type="doi">10.1001/jamanetworkopen.2024.52667</uri></p><p content-type="open-access-note"><bold>Open Access:</bold> This is an open access article distributed under the terms of the <ext-link xlink:href="https://jamanetwork.com/pages/cc-by-license-permissions" ext-link-type="uri">CC-BY License</ext-link>. &#x000a9; 2024 Hughes RT et al. <italic>JAMA Network Open</italic>.</p><corresp id="zoi241467cor1"><bold>Corresponding Author:</bold> Ryan T. Hughes, MD, Department of Radiation Oncology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157 (<email xlink:href="ryhughes@wakehealth.edu">ryhughes@wakehealth.edu</email>).</corresp><p content-type="author-contributions"><bold>Author Contributions:</bold> Drs Hughes and D&#x02019;Agostino had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.</p><p><italic>Concept and design:</italic> Hughes, Razavian, Bunch, Royce, Farris.</p><p><italic>Acquisition, analysis, or interpretation of data:</italic> Hughes, Razavian, Smith, D'Agostino, Ponnatapura, Royce, Ververs, Nightingale, Weaver, Farris.</p><p><italic>Drafting of the manuscript:</italic> Hughes, Razavian, Smith, D'Agostino, Royce, Farris.</p><p><italic>Critical review of the manuscript for important intellectual content:</italic> Hughes, Razavian, D'Agostino, Bunch, Ponnatapura, Royce, Ververs, Nightingale, Weaver, Farris.</p><p><italic>Statistical analysis:</italic> Hughes, Smith, D'Agostino, Nightingale.</p><p><italic>Administrative, technical, or material support:</italic> Hughes, Ververs.</p><p><italic>Supervision:</italic> Hughes, Razavian, Ponnatapura, Royce, Farris.</p><p content-type="COI-statement"><bold>Conflict of Interest Disclosures:</bold> Dr Bunch reported receiving personal fees from Guerbet outside the submitted work. Dr Weaver reported receiving grant funding from the National Institutes of Health (NIH) during the conduct of the study and outside the submitted work. No other disclosures were reported.</p><p content-type="funding-statement"><bold>Funding/Support:</bold> This work was supported by Early Career Investigator Award P30 Administrative Supplement award 3P 30CA012197-49S1 from the NIH (Dr Hughes) and by an Association of University Radiologists GE Radiology Research Academic Fellowship (Dr Bunch). We acknowledge the support of the Wake Forest Baptist Comprehensive Cancer Center Biostatistics Shared Resource, supported by Cancer Center Support Grant award number P30CA012197 from the National Cancer Institute.</p><p><bold>Role of the Funder/Sponsor:</bold> The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.</p><p><bold>Disclaimer:</bold> The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.</p><p content-type="data-sharing-statement"><bold>Data Sharing Statement:</bold> See <xref rid="note-ZOI241467-1-s" ref-type="supplementary-material">Supplement 2</xref>.</p></author-notes><pub-date pub-type="epub" iso-8601-date="2024-12-27T10:00"><day>27</day><month>12</month><year>2024</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2024</year></pub-date><pub-date pub-type="pmc-release"><day>27</day><month>12</month><year>2024</year></pub-date><!--PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>.--><volume>7</volume><issue>12</issue><elocation-id>e2452667</elocation-id><history><date date-type="received"><day>31</day><month>7</month><year>2024</year></date><date date-type="accepted"><day>28</day><month>10</month><year>2024</year></date></history><permissions><copyright-statement>Copyright 2024 Hughes RT et al. <italic>JAMA Network Open</italic>.</copyright-statement><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the CC-BY License.</license-p></license></permissions><self-uri content-type="pdf-version" xlink:href="jamanetwopen-e2452667.pdf">jamanetwopen-e2452667.pdf</self-uri><self-uri content-type="silverchair" xlink:href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.52667"/><abstract abstract-type="key-points"><title>Key Points</title><sec id="ab-zoi241467-1"><title>Question</title><p>What is the association of radiologist involvement in radiation oncology peer review with the radiotherapy plan?</p></sec><sec id="ab-zoi241467-2"><title>Findings</title><p>In this systematic review and meta-analysis of 31 studies reporting 39&#x02009;509 cases, significantly higher pooled rates of radiotherapy plan changes were observed with (49.4%) vs without (25.0%) radiologist involvement in peer review of contoured targets. Radiologist involvement was also associated with increases in major (47.0% vs 10.2%) but not minor (15.2% vs 13.8%) changes.</p></sec><sec id="ab-zoi241467-3"><title>Meaning</title><p>These results support the value of interdisciplinary collaboration with radiology during radiotherapy planning.</p></sec></abstract><abstract><sec id="ab-zoi241467-4"><title>Importance</title><p>Radiotherapy (RT) plan quality is an established predictive factor associated with cancer recurrence and survival outcomes. The addition of radiologists to the peer review (PR) process may increase RT plan quality.</p></sec><sec id="ab-zoi241467-5"><title>Objective</title><p>To determine the rate of changes to the RT plan with and without radiology involvement in PR of radiation targets.</p></sec><sec id="ab-zoi241467-6"><title>Data Sources</title><p>PubMed, Scopus, and Web of Science were queried for peer-reviewed articles published from inception up to March 6, 2024. Search terms included key words associated with PR of contoured targets for the purposes of RT planning with or without radiology involvement.</p></sec><sec id="ab-zoi241467-7"><title>Study Selection</title><p>Studies reporting PR of contoured radiation targets with or without radiology involvement. Studies were excluded if they lacked full text, reported clinical trial&#x02013;specific quality assurance, or reported PR without dedicated review of RT targets.</p></sec><sec id="ab-zoi241467-8"><title>Data Extraction and Synthesis</title><p>Data were extracted according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Titles and abstracts were screened by 2 reviewers. In the case of discordance, discussion was used to reach consensus regarding inclusion for full-text review. RT plan changes were characterized as major when the change was expected to have a substantial clinical impact, as defined by the original study. Pooled outcomes were estimated using random-effects models.</p></sec><sec id="ab-zoi241467-9"><title>Main Outcomes and Measures</title><p>Primary outcome was pooled rate of RT plan changes. Secondary outcomes included pooled rates of major and minor changes to RT targets or organs at risk.</p></sec><sec id="ab-zoi241467-10"><title>Results</title><p>Of 4185 screened studies, 31 reporting 39&#x02009;509 RT plans were included (390 with radiology and 39&#x02009;119 without). The pooled rate of plan changes was 29.0% (95% CI, 20.7%-37.2%). Radiologist participation in PR was associated with significant increases in plan change rates (49.4% [95% CI, 28.6%-70.1%] vs 25.0% [95% CI, 17.0%-33.1%]; <italic>P</italic>&#x02009;=&#x02009;.02) and in clinically relevant major changes (47.0% [95% CI, 34.1%-59.8%] vs 10.2% [95% CI, 4.6%-15.8%]; <italic>P</italic>&#x02009;&#x0003c;&#x02009;.001). There was no difference in minor changes (15.2% [95% CI, 9.7%-20.6%] vs 13.8% [95% CI, 9.3%-18.3%]; <italic>P</italic>&#x02009;=&#x02009;.74). Subgroup analyses identified increases in the rates of changes to the gross tumor and planning target volumes with radiology-based PR. The highest rates of plan changes were observed in head and neck or lung cancer studies, studies performing PR prior to RT planning, and prospective studies.</p></sec><sec id="ab-zoi241467-11"><title>Conclusions and Relevance</title><p>In this systematic review and meta-analysis of radiation oncology PR of contoured targets, radiologist involvement in peer review was associated with a significant increase in the rate of total and clinically meaningful changes to the RT targets with no change in minor change rates. These results support the value of interdisciplinary collaboration with radiology during RT planning.</p></sec></abstract><abstract abstract-type="teaser" specific-use="electronic"><p>This systemic review and meta-analysis assess published studies on radiation contour peer review to better understand the potential association of radiologist input with radiotherapy treatment plans for patients with cancer.</p></abstract></article-meta></front><body><sec id="H1-1-ZOI241467"><title>Introduction</title><p>Peer review (PR) of radiotherapy (RT) treatment plans is critical for radiation oncologists to ensure high-quality and safe treatment delivery.<sup><xref rid="zoi241467r1" ref-type="bibr">1</xref></sup> This process is a requirement for site accreditation by radiation oncology governing bodies such as the American College of Radiology and the American Society for Radiation Oncology. Conventional PR consists of standing meetings in which a patient&#x02019;s clinical scenario is presented and a general overview of their RT plan, including the site to be treated and RT prescription, is provided. While the specifics of the PR workflow vary by institution, the time spent reviewing each case is brief (approximately 2-3 minutes), and not all cases are reviewed.<sup><xref rid="zoi241467r2" ref-type="bibr">2</xref>,<xref rid="zoi241467r3" ref-type="bibr">3</xref>,<xref rid="zoi241467r4" ref-type="bibr">4</xref></sup> Given this format, it is challenging to ensure that all sites of disease are appropriately delineated and that normal tissues are adequately protected. To highlight this problem, a prospective study<sup><xref rid="zoi241467r5" ref-type="bibr">5</xref></sup> inserted erroneous plans into routine radiation oncology chart rounds and found that only 55% of errors were detected. Moreover, timeliness of PR is also critical: once the RT plan is finalized, the time and effort required to modify the plan based on reviewer feedback presents a barrier to consistent implementation of PR recommendations.</p><p>To address these challenges, multiple institutions have transitioned to focused PR of contoured targets and normal tissue structures.<sup><xref rid="zoi241467r3" ref-type="bibr">3</xref>,<xref rid="zoi241467r6" ref-type="bibr">6</xref>,<xref rid="zoi241467r7" ref-type="bibr">7</xref>,<xref rid="zoi241467r8" ref-type="bibr">8</xref>,<xref rid="zoi241467r9" ref-type="bibr">9</xref>,<xref rid="zoi241467r10" ref-type="bibr">10</xref>,<xref rid="zoi241467r11" ref-type="bibr">11</xref></sup> This process is critically important to radiation oncologists, since target and normal tissue structures are unique to each clinical scenario, and their delineation is a leading source of interphysician variability.<sup><xref rid="zoi241467r12" ref-type="bibr">12</xref></sup> Among modern RT techniques, one common source of variability is image interpretation: to develop highly conformal RT plans, radiation oncologists have become increasingly dependent on their ability to interpret multiple imaging modalities (eg, magnetic resonance imaging, positron emission tomography, computed tomography) during the RT planning process. While radiation oncologists are classically trained to interpret clinical scenarios and understand distribution of gross disease and potential routes of spread, radiation oncology residents are provided with limited formal training in diagnostic image interpretation. Despite 87% of residents agreeing that a strong radiological knowledge base is moderately to extremely important, more than 60% feel only &#x0201c;somewhat confident&#x0201d; in radiology at graduation.<sup><xref rid="zoi241467r13" ref-type="bibr">13</xref>,<xref rid="zoi241467r14" ref-type="bibr">14</xref>,<xref rid="zoi241467r15" ref-type="bibr">15</xref>,<xref rid="zoi241467r16" ref-type="bibr">16</xref>,<xref rid="zoi241467r17" ref-type="bibr">17</xref>,<xref rid="zoi241467r18" ref-type="bibr">18</xref></sup> In radiation oncology residency, radiological instruction is primarily in the form of multidisciplinary tumor board imaging review and on-the-job training during routine clinical care.<sup><xref rid="zoi241467r12" ref-type="bibr">12</xref></sup> Guidelines for RT target delineation are available, but these only provide a framework and do not improve image interpretation skills.<sup><xref rid="zoi241467r19" ref-type="bibr">19</xref>,<xref rid="zoi241467r20" ref-type="bibr">20</xref></sup> As a result, significant variability in tumor delineation may exist between radiation oncologists and radiologists.<sup><xref rid="zoi241467r21" ref-type="bibr">21</xref></sup></p><p>To address these challenges and bridge gaps in multidisciplinary care, some institutions have developed PR practices that embed radiologists into PR conferences to provide a more detailed radiological review of proposed treatments.<sup><xref rid="zoi241467r13" ref-type="bibr">13</xref>,<xref rid="zoi241467r14" ref-type="bibr">14</xref>,<xref rid="zoi241467r15" ref-type="bibr">15</xref>,<xref rid="zoi241467r16" ref-type="bibr">16</xref>,<xref rid="zoi241467r17" ref-type="bibr">17</xref>,<xref rid="zoi241467r18" ref-type="bibr">18</xref></sup> We performed a systematic review and meta-analysis of published studies on radiation contour PR to better understand the association of radiologist input with changes to RT treatment plans.</p></sec><sec id="H1-2-ZOI241467"><title>Methods</title><p>We performed a systematic review of the literature and meta-analysis according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (<ext-link xlink:href="http://www.equator-network.org/reporting-guidelines/prisma/" ext-link-type="uri">PRISMA</ext-link>) reporting guideline.<sup><xref rid="zoi241467r22" ref-type="bibr">22</xref></sup> This study was prospectively registered in the PROSPERO database (<ext-link xlink:href="https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=544451" ext-link-type="uri">CRD42024544451</ext-link>). Three databases (PubMed, Web of Science, and Scopus) were queried using standardized search terms to identify studies published from inception to March 6, 2024, that reported PR of contoured targets for the purposes of RT planning with or without radiology involvement. Search terms included (<italic>quality assurance</italic> OR <italic>peer review</italic> OR <italic>chart rounds</italic>) AND (<italic>contour</italic> OR <italic>contours</italic> OR <italic>contouring</italic> OR <italic>segmented</italic> OR <italic>delineated</italic> OR <italic>delineation</italic> OR <italic>target</italic> OR <italic>targets</italic> OR <italic>volume</italic> OR <italic>volume delineation</italic>) AND (<italic>radiotherapy</italic> OR <italic>radiation</italic> OR <italic>radiation therapy</italic>). Titles and abstracts were screened by 2 reviewers (R.T.H. and M.K.F.). In the case of discordance, discussion was used to reach consensus regarding inclusion for full-text review. Details on inclusion and exclusion criteria and the systematic review procedures are described in the eMethods in <xref rid="note-ZOI241467-1-s" ref-type="supplementary-material">Supplement 1</xref>. After full-text review, factors extracted from the studies included cancer diagnosis of patients reviewed, PR timing (before RT planning vs after plan completion), specific structures reviewed in PR, radiologist inclusion, definition of major and minor changes (if applicable), RT plan changes and recommendations for change, and changes to each specific type of target (eg, gross tumor volume [GTV], clinical target volume, planning target volume [PTV]). Quality of studies was assessed using the methodological index for nonrandomized studies.<sup><xref rid="zoi241467r23" ref-type="bibr">23</xref></sup> Scores range from 0 to 24, with higher scores indicating higher study quality; the ideal score is 16 for noncomparative studies and 24 for comparative studies.</p><p>The primary outcome of this study was the pooled rate of RT plan change of any kind after PR. These changes could relate to the contoured targets, organs at risk (OARs), prescribed dose, fractionation schedule, RT technique and modality, immobilization, motion management, imaging guidance, bolus or shielding, treatment intent, or treatment cancellation. To adequately capture PR outcomes, a combined outcome measure was used in this analysis: specifically, changes and recommended changes to RT plans were pooled together, regardless of whether they were documented as implemented by the included study. As secondary outcomes, major and minor changes were defined by the individual studies (eTable 1 in <xref rid="note-ZOI241467-1-s" ref-type="supplementary-material">Supplement 1</xref>); these study-level definitions were then used to categorize major and minor changes for the purposes of this analysis. Generally, major changes were defined as those expected to be clinically meaningful, by preventing geographic miss of gross tumor, affecting disease control outcomes, or affecting relevant toxic effects; minor changes were not expected to have substantial clinical importance. The total number of plan changes (of any type or significance) was extracted from studies, where reported, or calculated as the sum of major and minor changes, when these 2 change levels were reported separately. We evaluated the pooled rate of RT plan changes with and without radiology involvement in PR, as well as the pooled rate of change stratified by major and minor changes. We further looked at the rate of changes with and without radiology involvement specific to GTV, PTV, and OARs. Sensitivity analyses were also performed to assess the association of primary disease site, PR timing (before vs after the dosimetric planning process&#x02014;the act of creating and finalizing the RT plan based on the contoured target volumes), PR frequency (daily, multiple times per week, weekly, or as needed), and study type (prospective or retrospective) with RT plan changes.</p><sec id="H2-1-ZOI241467"><title>Statistical Analysis</title><p>The primary and secondary outcomes were estimated using a random-effects model, and heterogeneity was assessed using Cochran Q tests and the Higgins <italic>I</italic><sup>2</sup> statistic. In cases of high heterogeneity (<italic>I</italic><sup>2</sup>&#x02009;&#x0003e;&#x02009;50%), Cook distance was used to identify outliers, and pooled rates were recalculated after exclusion of outliers. Differences between subgroups were assessed using the omnibus test of moderators (Qm), testing the null hypothesis that all predictive factors entered into the model are unrelated to the observed effect sizes. Because only 1 study<sup><xref rid="zoi241467r18" ref-type="bibr">18</xref></sup> reported the outcomes of 2 groups undergoing PR with and without radiologist participation, models comparing effects of radiologist involvement across studies were not performed. Publication bias was assessed using funnel plots and the Egger regression test for plot symmetry.<sup><xref rid="zoi241467r24" ref-type="bibr">24</xref></sup> Statistical significance was defined using a 2-sided &#x003b1; of .05. All analyses were performed using the metafor package in R, version 4.4.1 (R Project for Statistical Computing),<sup><xref rid="zoi241467r25" ref-type="bibr">25</xref></sup> and RStudio, version 2024.09.0&#x02009;+&#x02009;375.<sup><xref rid="zoi241467r26" ref-type="bibr">26</xref></sup></p></sec></sec><sec id="H1-3-ZOI241467"><title>Results</title><sec id="H2-2-ZOI241467"><title>Characteristics of Included Studies</title><p>Systematic review identified 4185 studies for screening; 62 underwent full text review, and 31 with 39&#x02009;509 cases of PR were included in the pooled analysis (eFigure 1 in <xref rid="note-ZOI241467-1-s" ref-type="supplementary-material">Supplement 1</xref>).<sup><xref rid="zoi241467r3" ref-type="bibr">3</xref>,<xref rid="zoi241467r6" ref-type="bibr">6</xref>,<xref rid="zoi241467r7" ref-type="bibr">7</xref>,<xref rid="zoi241467r8" ref-type="bibr">8</xref>,<xref rid="zoi241467r9" ref-type="bibr">9</xref>,<xref rid="zoi241467r10" ref-type="bibr">10</xref>,<xref rid="zoi241467r11" ref-type="bibr">11</xref>,<xref rid="zoi241467r13" ref-type="bibr">13</xref>,<xref rid="zoi241467r14" ref-type="bibr">14</xref>,<xref rid="zoi241467r15" ref-type="bibr">15</xref>,<xref rid="zoi241467r16" ref-type="bibr">16</xref>,<xref rid="zoi241467r17" ref-type="bibr">17</xref>,<xref rid="zoi241467r18" ref-type="bibr">18</xref>,<xref rid="zoi241467r27" ref-type="bibr">27</xref>,<xref rid="zoi241467r28" ref-type="bibr">28</xref>,<xref rid="zoi241467r29" ref-type="bibr">29</xref>,<xref rid="zoi241467r30" ref-type="bibr">30</xref>,<xref rid="zoi241467r31" ref-type="bibr">31</xref>,<xref rid="zoi241467r32" ref-type="bibr">32</xref>,<xref rid="zoi241467r33" ref-type="bibr">33</xref>,<xref rid="zoi241467r34" ref-type="bibr">34</xref>,<xref rid="zoi241467r35" ref-type="bibr">35</xref>,<xref rid="zoi241467r36" ref-type="bibr">36</xref>,<xref rid="zoi241467r37" ref-type="bibr">37</xref>,<xref rid="zoi241467r38" ref-type="bibr">38</xref>,<xref rid="zoi241467r39" ref-type="bibr">39</xref>,<xref rid="zoi241467r40" ref-type="bibr">40</xref>,<xref rid="zoi241467r41" ref-type="bibr">41</xref>,<xref rid="zoi241467r42" ref-type="bibr">42</xref>,<xref rid="zoi241467r43" ref-type="bibr">43</xref>,<xref rid="zoi241467r44" ref-type="bibr">44</xref></sup> Characteristics of the included studies are presented in eTable 1 in <xref rid="note-ZOI241467-1-s" ref-type="supplementary-material">Supplement 1</xref>. Studies were published between 2014 and 2024; 18 were prospective<sup><xref rid="zoi241467r3" ref-type="bibr">3</xref>,<xref rid="zoi241467r6" ref-type="bibr">6</xref>,<xref rid="zoi241467r10" ref-type="bibr">10</xref>,<xref rid="zoi241467r11" ref-type="bibr">11</xref>,<xref rid="zoi241467r13" ref-type="bibr">13</xref>,<xref rid="zoi241467r15" ref-type="bibr">15</xref>,<xref rid="zoi241467r17" ref-type="bibr">17</xref>,<xref rid="zoi241467r18" ref-type="bibr">18</xref>,<xref rid="zoi241467r27" ref-type="bibr">27</xref>,<xref rid="zoi241467r29" ref-type="bibr">29</xref>,<xref rid="zoi241467r33" ref-type="bibr">33</xref>,<xref rid="zoi241467r34" ref-type="bibr">34</xref>,<xref rid="zoi241467r37" ref-type="bibr">37</xref>,<xref rid="zoi241467r38" ref-type="bibr">38</xref>,<xref rid="zoi241467r39" ref-type="bibr">39</xref>,<xref rid="zoi241467r40" ref-type="bibr">40</xref>,<xref rid="zoi241467r41" ref-type="bibr">41</xref>,<xref rid="zoi241467r44" ref-type="bibr">44</xref></sup> and 13 were retrospective.<sup><xref rid="zoi241467r7" ref-type="bibr">7</xref>,<xref rid="zoi241467r8" ref-type="bibr">8</xref>,<xref rid="zoi241467r9" ref-type="bibr">9</xref>,<xref rid="zoi241467r14" ref-type="bibr">14</xref>,<xref rid="zoi241467r16" ref-type="bibr">16</xref>,<xref rid="zoi241467r28" ref-type="bibr">28</xref>,<xref rid="zoi241467r30" ref-type="bibr">30</xref>,<xref rid="zoi241467r31" ref-type="bibr">31</xref>,<xref rid="zoi241467r32" ref-type="bibr">32</xref>,<xref rid="zoi241467r35" ref-type="bibr">35</xref>,<xref rid="zoi241467r36" ref-type="bibr">36</xref>,<xref rid="zoi241467r42" ref-type="bibr">42</xref>,<xref rid="zoi241467r43" ref-type="bibr">43</xref></sup> By specific cancer diagnosis, PR of head and neck cancer (n&#x02009;=&#x02009;11)<sup><xref rid="zoi241467r13" ref-type="bibr">13</xref>,<xref rid="zoi241467r14" ref-type="bibr">14</xref>,<xref rid="zoi241467r15" ref-type="bibr">15</xref>,<xref rid="zoi241467r17" ref-type="bibr">17</xref>,<xref rid="zoi241467r18" ref-type="bibr">18</xref>,<xref rid="zoi241467r27" ref-type="bibr">27</xref>,<xref rid="zoi241467r30" ref-type="bibr">30</xref>,<xref rid="zoi241467r36" ref-type="bibr">36</xref>,<xref rid="zoi241467r37" ref-type="bibr">37</xref>,<xref rid="zoi241467r38" ref-type="bibr">38</xref>,<xref rid="zoi241467r40" ref-type="bibr">40</xref></sup> and multiple diagnoses (n&#x02009;=&#x02009;12)<sup><xref rid="zoi241467r3" ref-type="bibr">3</xref>,<xref rid="zoi241467r6" ref-type="bibr">6</xref>,<xref rid="zoi241467r7" ref-type="bibr">7</xref>,<xref rid="zoi241467r8" ref-type="bibr">8</xref>,<xref rid="zoi241467r9" ref-type="bibr">9</xref>,<xref rid="zoi241467r10" ref-type="bibr">10</xref>,<xref rid="zoi241467r11" ref-type="bibr">11</xref>,<xref rid="zoi241467r16" ref-type="bibr">16</xref>,<xref rid="zoi241467r31" ref-type="bibr">31</xref>,<xref rid="zoi241467r33" ref-type="bibr">33</xref>,<xref rid="zoi241467r42" ref-type="bibr">42</xref>,<xref rid="zoi241467r43" ref-type="bibr">43</xref></sup> were most common, followed by stereotactic body RT (SBRT) at various sites (n&#x02009;=&#x02009;3),<sup><xref rid="zoi241467r32" ref-type="bibr">32</xref>,<xref rid="zoi241467r35" ref-type="bibr">35</xref>,<xref rid="zoi241467r39" ref-type="bibr">39</xref></sup> and lung cancer (n&#x02009;=&#x02009;2)<sup><xref rid="zoi241467r29" ref-type="bibr">29</xref>,<xref rid="zoi241467r44" ref-type="bibr">44</xref></sup>; the remaining 3 studies included patients with other diagnoses including breast,<sup><xref rid="zoi241467r34" ref-type="bibr">34</xref></sup> gynecologic,<sup><xref rid="zoi241467r41" ref-type="bibr">41</xref></sup> or hematologic cancers.<sup><xref rid="zoi241467r28" ref-type="bibr">28</xref></sup> Fifteen studies<sup><xref rid="zoi241467r13" ref-type="bibr">13</xref>,<xref rid="zoi241467r14" ref-type="bibr">14</xref>,<xref rid="zoi241467r15" ref-type="bibr">15</xref>,<xref rid="zoi241467r16" ref-type="bibr">16</xref>,<xref rid="zoi241467r17" ref-type="bibr">17</xref>,<xref rid="zoi241467r18" ref-type="bibr">18</xref>,<xref rid="zoi241467r27" ref-type="bibr">27</xref>,<xref rid="zoi241467r28" ref-type="bibr">28</xref>,<xref rid="zoi241467r32" ref-type="bibr">32</xref>,<xref rid="zoi241467r36" ref-type="bibr">36</xref>,<xref rid="zoi241467r37" ref-type="bibr">37</xref>,<xref rid="zoi241467r38" ref-type="bibr">38</xref>,<xref rid="zoi241467r40" ref-type="bibr">40</xref>,<xref rid="zoi241467r41" ref-type="bibr">41</xref>,<xref rid="zoi241467r44" ref-type="bibr">44</xref></sup> reported PR prior to initiation of treatment planning, 9 studies<sup><xref rid="zoi241467r3" ref-type="bibr">3</xref>,<xref rid="zoi241467r7" ref-type="bibr">7</xref>,<xref rid="zoi241467r9" ref-type="bibr">9</xref>,<xref rid="zoi241467r29" ref-type="bibr">29</xref>,<xref rid="zoi241467r31" ref-type="bibr">31</xref>,<xref rid="zoi241467r34" ref-type="bibr">34</xref>,<xref rid="zoi241467r35" ref-type="bibr">35</xref>,<xref rid="zoi241467r42" ref-type="bibr">42</xref>,<xref rid="zoi241467r43" ref-type="bibr">43</xref></sup> reviewed contours after planning, and 7 studies<sup><xref rid="zoi241467r6" ref-type="bibr">6</xref>,<xref rid="zoi241467r8" ref-type="bibr">8</xref>,<xref rid="zoi241467r10" ref-type="bibr">10</xref>,<xref rid="zoi241467r11" ref-type="bibr">11</xref>,<xref rid="zoi241467r30" ref-type="bibr">30</xref>,<xref rid="zoi241467r33" ref-type="bibr">33</xref>,<xref rid="zoi241467r38" ref-type="bibr">38</xref></sup> reported a mix of preplanning and postplanning PR. Twenty-four studies<sup><xref rid="zoi241467r3" ref-type="bibr">3</xref>,<xref rid="zoi241467r7" ref-type="bibr">7</xref>,<xref rid="zoi241467r8" ref-type="bibr">8</xref>,<xref rid="zoi241467r9" ref-type="bibr">9</xref>,<xref rid="zoi241467r10" ref-type="bibr">10</xref>,<xref rid="zoi241467r11" ref-type="bibr">11</xref>,<xref rid="zoi241467r13" ref-type="bibr">13</xref>,<xref rid="zoi241467r14" ref-type="bibr">14</xref>,<xref rid="zoi241467r15" ref-type="bibr">15</xref>,<xref rid="zoi241467r16" ref-type="bibr">16</xref>,<xref rid="zoi241467r17" ref-type="bibr">17</xref>,<xref rid="zoi241467r18" ref-type="bibr">18</xref>,<xref rid="zoi241467r27" ref-type="bibr">27</xref>,<xref rid="zoi241467r30" ref-type="bibr">30</xref>,<xref rid="zoi241467r31" ref-type="bibr">31</xref>,<xref rid="zoi241467r33" ref-type="bibr">33</xref>,<xref rid="zoi241467r34" ref-type="bibr">34</xref>,<xref rid="zoi241467r35" ref-type="bibr">35</xref>,<xref rid="zoi241467r36" ref-type="bibr">36</xref>,<xref rid="zoi241467r37" ref-type="bibr">37</xref>,<xref rid="zoi241467r38" ref-type="bibr">38</xref>,<xref rid="zoi241467r40" ref-type="bibr">40</xref>,<xref rid="zoi241467r41" ref-type="bibr">41</xref>,<xref rid="zoi241467r42" ref-type="bibr">42</xref>,<xref rid="zoi241467r43" ref-type="bibr">43</xref></sup> indicated the clinical importance of PR changes, while 7 studies<sup><xref rid="zoi241467r6" ref-type="bibr">6</xref>,<xref rid="zoi241467r16" ref-type="bibr">16</xref>,<xref rid="zoi241467r17" ref-type="bibr">17</xref>,<xref rid="zoi241467r28" ref-type="bibr">28</xref>,<xref rid="zoi241467r29" ref-type="bibr">29</xref>,<xref rid="zoi241467r32" ref-type="bibr">32</xref>,<xref rid="zoi241467r39" ref-type="bibr">39</xref></sup> did not. Clinical importance was reported as major vs minor changes (most common), clinically significant vs clinically insignificant (or noncritical), letter grades (ie, A [no changes], B [minor changes], and C [major changes]), or stoplight scoring (red indicating major changes and yellow indicating minor changes). The definitions of the severity of major and minor changes are shown in eTable 1 in <xref rid="note-ZOI241467-1-s" ref-type="supplementary-material">Supplement 1</xref>. In terms of contours examined during PR, 30 studies reported reviewing target structures: 15 studies<sup><xref rid="zoi241467r3" ref-type="bibr">3</xref>,<xref rid="zoi241467r9" ref-type="bibr">9</xref>,<xref rid="zoi241467r10" ref-type="bibr">10</xref>,<xref rid="zoi241467r18" ref-type="bibr">18</xref>,<xref rid="zoi241467r27" ref-type="bibr">27</xref>,<xref rid="zoi241467r29" ref-type="bibr">29</xref>,<xref rid="zoi241467r31" ref-type="bibr">31</xref>,<xref rid="zoi241467r33" ref-type="bibr">33</xref>,<xref rid="zoi241467r34" ref-type="bibr">34</xref>,<xref rid="zoi241467r35" ref-type="bibr">35</xref>,<xref rid="zoi241467r39" ref-type="bibr">39</xref>,<xref rid="zoi241467r40" ref-type="bibr">40</xref></sup> reviewed all targets and OARs, 13 studies<sup><xref rid="zoi241467r8" ref-type="bibr">8</xref>,<xref rid="zoi241467r11" ref-type="bibr">11</xref>,<xref rid="zoi241467r13" ref-type="bibr">13</xref>,<xref rid="zoi241467r14" ref-type="bibr">14</xref>,<xref rid="zoi241467r15" ref-type="bibr">15</xref>,<xref rid="zoi241467r16" ref-type="bibr">16</xref>,<xref rid="zoi241467r17" ref-type="bibr">17</xref>,<xref rid="zoi241467r28" ref-type="bibr">28</xref>,<xref rid="zoi241467r30" ref-type="bibr">30</xref>,<xref rid="zoi241467r32" ref-type="bibr">32</xref>,<xref rid="zoi241467r36" ref-type="bibr">36</xref>,<xref rid="zoi241467r38" ref-type="bibr">38</xref>,<xref rid="zoi241467r41" ref-type="bibr">41</xref></sup> reviewed only targets, and 2 studies<sup><xref rid="zoi241467r6" ref-type="bibr">6</xref>,<xref rid="zoi241467r37" ref-type="bibr">37</xref></sup> reviewed only specific targets and OARs. Regarding the intent of RT for cases undergoing PR, pooled rate of curative intent was 93.7%; palliative intent, 6.3%; definitive intent, 62.0%; and adjuvant or neoadjuvant intent, 35.8% (eTable 2 in <xref rid="note-ZOI241467-1-s" ref-type="supplementary-material">Supplement 1</xref>). Median study quality (per the methodological index for nonrandomized studies) was 8 (range, 5-10) (eTable 3 in <xref rid="note-ZOI241467-1-s" ref-type="supplementary-material">Supplement 1</xref>). No evidence of publication bias was identified across studies (Egger test <italic>P</italic>&#x02009;=&#x02009;.56) (eFigure 2 in <xref rid="note-ZOI241467-1-s" ref-type="supplementary-material">Supplement 1</xref>).</p></sec><sec id="H2-3-ZOI241467"><title>RT Plan Changes With and Without Radiology Involvement in PR</title><p>A total of 6 studies (390 cases)<sup><xref rid="zoi241467r13" ref-type="bibr">13</xref>,<xref rid="zoi241467r14" ref-type="bibr">14</xref>,<xref rid="zoi241467r15" ref-type="bibr">15</xref>,<xref rid="zoi241467r16" ref-type="bibr">16</xref>,<xref rid="zoi241467r17" ref-type="bibr">17</xref>,<xref rid="zoi241467r18" ref-type="bibr">18</xref></sup> reported outcomes of PR in the presence of radiologists, while 25 studies (39&#x02009;1196 cases)<sup><xref rid="zoi241467r3" ref-type="bibr">3</xref>,<xref rid="zoi241467r6" ref-type="bibr">6</xref>,<xref rid="zoi241467r7" ref-type="bibr">7</xref>,<xref rid="zoi241467r8" ref-type="bibr">8</xref>,<xref rid="zoi241467r9" ref-type="bibr">9</xref>,<xref rid="zoi241467r10" ref-type="bibr">10</xref>,<xref rid="zoi241467r11" ref-type="bibr">11</xref>,<xref rid="zoi241467r27" ref-type="bibr">27</xref>,<xref rid="zoi241467r28" ref-type="bibr">28</xref>,<xref rid="zoi241467r29" ref-type="bibr">29</xref>,<xref rid="zoi241467r30" ref-type="bibr">30</xref>,<xref rid="zoi241467r31" ref-type="bibr">31</xref>,<xref rid="zoi241467r32" ref-type="bibr">32</xref>,<xref rid="zoi241467r33" ref-type="bibr">33</xref>,<xref rid="zoi241467r34" ref-type="bibr">34</xref>,<xref rid="zoi241467r35" ref-type="bibr">35</xref>,<xref rid="zoi241467r36" ref-type="bibr">36</xref>,<xref rid="zoi241467r37" ref-type="bibr">37</xref>,<xref rid="zoi241467r38" ref-type="bibr">38</xref>,<xref rid="zoi241467r39" ref-type="bibr">39</xref>,<xref rid="zoi241467r40" ref-type="bibr">40</xref>,<xref rid="zoi241467r41" ref-type="bibr">41</xref>,<xref rid="zoi241467r42" ref-type="bibr">42</xref>,<xref rid="zoi241467r43" ref-type="bibr">43</xref>,<xref rid="zoi241467r44" ref-type="bibr">44</xref></sup> reported PR without radiologist involvement. The pooled rate of RT plan changes was significantly higher among studies that incorporated radiologists in PR than studies that did not at 49.4% (95% CI, 28.6%-70.1%) vs 25.0% (95% CI, 17.0%-33.1%), respectively (<italic>P</italic>&#x02009;=&#x02009;.02) (<xref rid="zoi241467f1" ref-type="fig">Figure 1</xref>). In the 24 studies that reported major and minor changes,<sup><xref rid="zoi241467r3" ref-type="bibr">3</xref>,<xref rid="zoi241467r7" ref-type="bibr">7</xref>,<xref rid="zoi241467r8" ref-type="bibr">8</xref>,<xref rid="zoi241467r9" ref-type="bibr">9</xref>,<xref rid="zoi241467r11" ref-type="bibr">11</xref>,<xref rid="zoi241467r13" ref-type="bibr">13</xref>,<xref rid="zoi241467r14" ref-type="bibr">14</xref>,<xref rid="zoi241467r15" ref-type="bibr">15</xref>,<xref rid="zoi241467r17" ref-type="bibr">17</xref>,<xref rid="zoi241467r18" ref-type="bibr">18</xref>,<xref rid="zoi241467r27" ref-type="bibr">27</xref>,<xref rid="zoi241467r30" ref-type="bibr">30</xref>,<xref rid="zoi241467r31" ref-type="bibr">31</xref>,<xref rid="zoi241467r33" ref-type="bibr">33</xref>,<xref rid="zoi241467r34" ref-type="bibr">34</xref>,<xref rid="zoi241467r35" ref-type="bibr">35</xref>,<xref rid="zoi241467r36" ref-type="bibr">36</xref>,<xref rid="zoi241467r37" ref-type="bibr">37</xref>,<xref rid="zoi241467r38" ref-type="bibr">38</xref>,<xref rid="zoi241467r40" ref-type="bibr">40</xref>,<xref rid="zoi241467r41" ref-type="bibr">41</xref>,<xref rid="zoi241467r42" ref-type="bibr">42</xref>,<xref rid="zoi241467r43" ref-type="bibr">43</xref></sup> the involvement of radiology in PR was associated with an increased rate of major RT plan changes (47.0% [95% CI, 34.1%-59.8%] vs 10.2% [95% CI, 4.6%-15.8%]; <italic>P</italic>&#x02009;&#x0003c;&#x02009;.001) (<xref rid="zoi241467f2" ref-type="fig">Figure 2</xref>) but no difference in minor changes (15.2% [95% CI, 9.7%-20.6%] vs 13.8% [95% CI, 9.3%-18.3%]; <italic>P</italic>&#x02009;=&#x02009;.74) (<xref rid="zoi241467f3" ref-type="fig">Figure 3</xref>). Given the high level of heterogeneity observed, these primary analyses were repeated after the removal of outliers. After removal of outlier studies, heterogeneity remained high in the group that did not include a radiologist, but the outcomes were not substantially different from those observed in the analysis of the total cohort for all changes, major changes, and minor changes.</p><fig position="float" id="zoi241467f1" fig-type="figure"><label>Figure 1. </label><caption><title>Forest Plot and Pooled Rates of Any Plan Changes by Radiology Involvement in Radiotherapy Peer Review</title><p>Vertical line indicates the pooled rate for all studies. Light blue diamonds represent pooled rates and 95% CIs. RE indicates random effects.</p><p><sup>a</sup>Subgroup reviewed without radiologist.</p><p><sup>b</sup>Subgroup reviewed with radiologist.</p></caption><graphic xlink:href="jamanetwopen-e2452667-g001" position="float"/></fig><fig position="float" id="zoi241467f2" fig-type="figure"><label>Figure 2. </label><caption><title>Forest Plot and Pooled Rates of Major Changes to the Radiotherapy Plan by Radiology Involvement</title><p>Studies that did not differentiate changes as major vs minor (n&#x02009;=&#x02009;7) were excluded from this analysis. Vertical line indicates the pooled rate for all studies. Tan shaded areas indicate that the lower confidence bound crosses 0; light blue diamonds represent pooled rates and 95% CIs. RE indicates random effects.</p><p><sup>a</sup>Subgroup reviewed without radiologist.</p><p><sup>b</sup>Subgroup reviewed with radiologist.</p></caption><graphic xlink:href="jamanetwopen-e2452667-g002" position="float"/></fig><fig position="float" id="zoi241467f3" fig-type="figure"><label>Figure 3. </label><caption><title>Forest Plot and Pooled Rates of Minor Changes to the Radiotherapy Plan by Radiology Involvement</title><p>Studies that did not differentiate changes as major vs minor (n&#x02009;=&#x02009;7) were excluded from this analysis. Vertical line indicates the pooled rate for all studies. Light blue diamonds represent pooled rates and 95% CIs. RE indicates random effects.</p><p><sup>a</sup>Subgroup reviewed without radiologist.</p><p><sup>b</sup>Subgroup reviewed with radiologist.</p></caption><graphic xlink:href="jamanetwopen-e2452667-g003" position="float"/></fig><p>Subgroup analyses were performed on the studies reporting changes to specific contoured volumes because of PR, including GTV (12 studies; 1814 cases),<sup><xref rid="zoi241467r13" ref-type="bibr">13</xref>,<xref rid="zoi241467r14" ref-type="bibr">14</xref>,<xref rid="zoi241467r16" ref-type="bibr">16</xref>,<xref rid="zoi241467r17" ref-type="bibr">17</xref>,<xref rid="zoi241467r18" ref-type="bibr">18</xref>,<xref rid="zoi241467r27" ref-type="bibr">27</xref>,<xref rid="zoi241467r28" ref-type="bibr">28</xref>,<xref rid="zoi241467r30" ref-type="bibr">30</xref>,<xref rid="zoi241467r32" ref-type="bibr">32</xref>,<xref rid="zoi241467r38" ref-type="bibr">38</xref>,<xref rid="zoi241467r44" ref-type="bibr">44</xref></sup> PTV and treatment volumes (21 studies; 35&#x02009;205 cases),<sup><xref rid="zoi241467r7" ref-type="bibr">7</xref>,<xref rid="zoi241467r8" ref-type="bibr">8</xref>,<xref rid="zoi241467r9" ref-type="bibr">9</xref>,<xref rid="zoi241467r10" ref-type="bibr">10</xref>,<xref rid="zoi241467r11" ref-type="bibr">11</xref>,<xref rid="zoi241467r13" ref-type="bibr">13</xref>,<xref rid="zoi241467r14" ref-type="bibr">14</xref>,<xref rid="zoi241467r16" ref-type="bibr">16</xref>,<xref rid="zoi241467r17" ref-type="bibr">17</xref>,<xref rid="zoi241467r18" ref-type="bibr">18</xref>,<xref rid="zoi241467r27" ref-type="bibr">27</xref>,<xref rid="zoi241467r28" ref-type="bibr">28</xref>,<xref rid="zoi241467r29" ref-type="bibr">29</xref>,<xref rid="zoi241467r32" ref-type="bibr">32</xref>,<xref rid="zoi241467r33" ref-type="bibr">33</xref>,<xref rid="zoi241467r34" ref-type="bibr">34</xref>,<xref rid="zoi241467r38" ref-type="bibr">38</xref>,<xref rid="zoi241467r39" ref-type="bibr">39</xref>,<xref rid="zoi241467r41" ref-type="bibr">41</xref>,<xref rid="zoi241467r42" ref-type="bibr">42</xref></sup> and OARs (12 studies; 31&#x02009;023 cases).<sup><xref rid="zoi241467r7" ref-type="bibr">7</xref>,<xref rid="zoi241467r9" ref-type="bibr">9</xref>,<xref rid="zoi241467r10" ref-type="bibr">10</xref>,<xref rid="zoi241467r16" ref-type="bibr">16</xref>,<xref rid="zoi241467r17" ref-type="bibr">17</xref>,<xref rid="zoi241467r18" ref-type="bibr">18</xref>,<xref rid="zoi241467r27" ref-type="bibr">27</xref>,<xref rid="zoi241467r28" ref-type="bibr">28</xref>,<xref rid="zoi241467r34" ref-type="bibr">34</xref>,<xref rid="zoi241467r39" ref-type="bibr">39</xref>,<xref rid="zoi241467r41" ref-type="bibr">41</xref></sup> Radiologist-involved PR was associated with significant increases in rates of change to the GTV (41.0% [95% CI, 15.8%-66.2%] vs 4.1% [95% CI, 1.,2%-7.1%]; <italic>P</italic>&#x02009;&#x0003c;&#x02009;.001) (<xref rid="zoi241467f4" ref-type="fig">Figure 4</xref>) and PTV and target volumes (45.6% [95% CI, 13.5%-77.8%] vs 18.5% [95% CI, 8.7%-28.3%]; <italic>P</italic>&#x02009;=&#x02009;.04) (<xref rid="zoi241467f5" ref-type="fig">Figure 5</xref>), but not to OARs (4.1% [95% CI, &#x02212;4.5% to 12.7%] vs 4.3% [95% CI, &#x02212;0.6% to 9.2%]; <italic>P</italic>&#x02009;=&#x02009;.98) (eFigure 3 in <xref rid="note-ZOI241467-1-s" ref-type="supplementary-material">Supplement 1</xref>).</p><fig position="float" id="zoi241467f4" fig-type="figure"><label>Figure 4. </label><caption><title>Forest Plot and Pooled Rates of Changes to the Gross Tumor Volume by Radiology Involvement</title><p>Vertical lines indicate the pooled rates for each subgroup. Tan shaded areas indicate that the lower confidence bound crosses 0; light blue diamonds represent pooled rates and 95% CIs. RE indicates random effects.</p><p><sup>a</sup>Subgroup reviewed without radiologist.</p><p><sup>b</sup>Subgroup reviewed with radiologist.</p></caption><graphic xlink:href="jamanetwopen-e2452667-g004" position="float"/></fig><fig position="float" id="zoi241467f5" fig-type="figure"><label>Figure 5. </label><caption><title>Forest Plot and Pooled Rates of Changes to the Planning Target Volume or Treatment Volume by Radiology Involvement</title><p>Vertical line indicates the pooled rate for all studies. Light blue diamonds represent pooled rates and 95% CIs. RE indicates random effects.</p><p><sup>a</sup>Subgroup reviewed without radiologist.</p><p><sup>b</sup>Subgroup reviewed with radiologist.</p></caption><graphic xlink:href="jamanetwopen-e2452667-g005" position="float"/></fig><p>We also examined pooled rates according to the specific change outcome reported. Twenty-one studies<sup><xref rid="zoi241467r3" ref-type="bibr">3</xref>,<xref rid="zoi241467r6" ref-type="bibr">6</xref>,<xref rid="zoi241467r7" ref-type="bibr">7</xref>,<xref rid="zoi241467r8" ref-type="bibr">8</xref>,<xref rid="zoi241467r10" ref-type="bibr">10</xref>,<xref rid="zoi241467r13" ref-type="bibr">13</xref>,<xref rid="zoi241467r14" ref-type="bibr">14</xref>,<xref rid="zoi241467r15" ref-type="bibr">15</xref>,<xref rid="zoi241467r16" ref-type="bibr">16</xref>,<xref rid="zoi241467r17" ref-type="bibr">17</xref>,<xref rid="zoi241467r18" ref-type="bibr">18</xref>,<xref rid="zoi241467r29" ref-type="bibr">29</xref>,<xref rid="zoi241467r32" ref-type="bibr">32</xref>,<xref rid="zoi241467r34" ref-type="bibr">34</xref>,<xref rid="zoi241467r35" ref-type="bibr">35</xref>,<xref rid="zoi241467r40" ref-type="bibr">40</xref>,<xref rid="zoi241467r41" ref-type="bibr">41</xref>,<xref rid="zoi241467r43" ref-type="bibr">43</xref>,<xref rid="zoi241467r44" ref-type="bibr">44</xref></sup> reported RT plan changes (eFigure 4 in <xref rid="note-ZOI241467-1-s" ref-type="supplementary-material">Supplement 1</xref>), and 14 studies<sup><xref rid="zoi241467r6" ref-type="bibr">6</xref>,<xref rid="zoi241467r9" ref-type="bibr">9</xref>,<xref rid="zoi241467r11" ref-type="bibr">11</xref>,<xref rid="zoi241467r17" ref-type="bibr">17</xref>,<xref rid="zoi241467r27" ref-type="bibr">27</xref>,<xref rid="zoi241467r28" ref-type="bibr">28</xref>,<xref rid="zoi241467r30" ref-type="bibr">30</xref>,<xref rid="zoi241467r31" ref-type="bibr">31</xref>,<xref rid="zoi241467r33" ref-type="bibr">33</xref>,<xref rid="zoi241467r36" ref-type="bibr">36</xref>,<xref rid="zoi241467r37" ref-type="bibr">37</xref>,<xref rid="zoi241467r39" ref-type="bibr">39</xref>,<xref rid="zoi241467r42" ref-type="bibr">42</xref>,<xref rid="zoi241467r44" ref-type="bibr">44</xref></sup> reported recommendations for plan changes (eFigure 5 in <xref rid="note-ZOI241467-1-s" ref-type="supplementary-material">Supplement 1</xref>); the pooled rates of each were 32.3% (95% CI, 20.7%-43.8%) and 22.4% (95% CI, 16.3%-28.5%), respectively. Among all 31 studies,<sup><xref rid="zoi241467r3" ref-type="bibr">3</xref>,<xref rid="zoi241467r6" ref-type="bibr">6</xref>,<xref rid="zoi241467r7" ref-type="bibr">7</xref>,<xref rid="zoi241467r8" ref-type="bibr">8</xref>,<xref rid="zoi241467r9" ref-type="bibr">9</xref>,<xref rid="zoi241467r10" ref-type="bibr">10</xref>,<xref rid="zoi241467r11" ref-type="bibr">11</xref>,<xref rid="zoi241467r13" ref-type="bibr">13</xref>,<xref rid="zoi241467r14" ref-type="bibr">14</xref>,<xref rid="zoi241467r15" ref-type="bibr">15</xref>,<xref rid="zoi241467r16" ref-type="bibr">16</xref>,<xref rid="zoi241467r17" ref-type="bibr">17</xref>,<xref rid="zoi241467r18" ref-type="bibr">18</xref>,<xref rid="zoi241467r27" ref-type="bibr">27</xref>,<xref rid="zoi241467r28" ref-type="bibr">28</xref>,<xref rid="zoi241467r29" ref-type="bibr">29</xref>,<xref rid="zoi241467r30" ref-type="bibr">30</xref>,<xref rid="zoi241467r31" ref-type="bibr">31</xref>,<xref rid="zoi241467r32" ref-type="bibr">32</xref>,<xref rid="zoi241467r33" ref-type="bibr">33</xref>,<xref rid="zoi241467r34" ref-type="bibr">34</xref>,<xref rid="zoi241467r35" ref-type="bibr">35</xref>,<xref rid="zoi241467r36" ref-type="bibr">36</xref>,<xref rid="zoi241467r37" ref-type="bibr">37</xref>,<xref rid="zoi241467r38" ref-type="bibr">38</xref>,<xref rid="zoi241467r39" ref-type="bibr">39</xref>,<xref rid="zoi241467r40" ref-type="bibr">40</xref>,<xref rid="zoi241467r41" ref-type="bibr">41</xref>,<xref rid="zoi241467r42" ref-type="bibr">42</xref>,<xref rid="zoi241467r43" ref-type="bibr">43</xref>,<xref rid="zoi241467r44" ref-type="bibr">44</xref></sup> the pooled rate of RT plan recommendations and changes was 29.0% (95% CI, 20.7%-37.2%) (eFigure 6 in <xref rid="note-ZOI241467-1-s" ref-type="supplementary-material">Supplement 1</xref>).</p></sec><sec id="H2-4-ZOI241467"><title>Subgroup Analyses of Plan Changes Based on PR and Study Factors</title><p>To better understand the association of the nature, frequency, and timing of PR with RT plan changes, subgroup analyses on the following factors were performed on all included studies: disease site and technique of RT plans being reviewed (all, head and neck, lung, SBRT of multiple sites, and other individual sites), frequency of PR (daily, multiple times per week, weekly, or as needed), and timing of PR relative to the RT planning process (before RT plan initiation or completion vs after or both). There were significant differences in RT plan changes between reports based on RT plan site and technique (eFigure 7 in <xref rid="note-ZOI241467-1-s" ref-type="supplementary-material">Supplement 1</xref>), with studies reporting head and neck PR observing the highest rates of changes (44.9%; 95% CI, 31.3%-58.4%), followed by other sites (38.5%; 95% CI, &#x02212;16.9% to 93.9%), lung (24.5%; 95% CI, 10.3%-37.8%), SBRT (17.4%; 95% CI, 2.7%-32.0%), and all or multiple sites (15.9%; 95% CI, 11.4%-20.4%) (<italic>P</italic>&#x02009;=&#x02009;.01). There were also significant differences in plan change rates based on the timing of PR (eFigure 8 in <xref rid="note-ZOI241467-1-s" ref-type="supplementary-material">Supplement 1</xref>): studies reporting PR that was performed before RT planning observed a significantly higher rate (43.5%; 95% CI, 30.1%-56.8%) than those reporting PR after planning initiation or completion (11.4%; 95% CI, 6.9%-15.9%) or both before and after planning (21.0%; 95% CI, 15.8%-26.1%) (<italic>P</italic>&#x02009;&#x0003c;&#x02009;.001). There was no difference in change rates based on the frequency of PR (eFigure 9 in <xref rid="note-ZOI241467-1-s" ref-type="supplementary-material">Supplement 1</xref>). When comparing studies reporting prospective vs retrospective analyses of PR outcomes, a significantly higher rate of changes was observed in prospective studies (36.7%; 95% CI, 25.4%-48.1%) than in retrospective studies (16.6%; 95% CI, 9.1%-24.2%) (<italic>P</italic>&#x02009;=&#x02009;.01) (eFigure 10 in <xref rid="note-ZOI241467-1-s" ref-type="supplementary-material">Supplement 1</xref>). An association between radiologist involvement and plan changes was only observed in prospective studies (eFigures 11 and 12 in <xref rid="note-ZOI241467-1-s" ref-type="supplementary-material">Supplement 1</xref>).</p></sec></sec><sec id="H1-4-ZOI241467"><title>Discussion</title><p>Curative RT is predicated on accurate, millimeter-precise treatment planning and delivery. Interdisciplinary collaboration between radiation oncologists and diagnostic radiologists may further refine this highly technical process, optimize RT targeting, and improve cancer treatment outcomes. In this systematic review and meta-analysis, we found a 36.8% higher absolute rate of clinically significant changes to the RT plan associated with radiologist inclusion in radiation oncology peer review of contoured volumes. Importantly, we did not observe a significant difference in minor changes, seemingly indicating that radiologist collaboration in PR meaningfully impacts RT plans without added change burden for minor issues. These findings are additionally important because PR is required for radiation oncology practice accreditation, and prior studies have shown RT plan quality directly affects cancer recurrence, progression, and survival.<sup><xref rid="zoi241467r45" ref-type="bibr">45</xref>,<xref rid="zoi241467r46" ref-type="bibr">46</xref></sup></p><p>While multiple studies have been published on PR with or without radiology involvement, few have compared PR outcomes between the 2 approaches. Only one of these experiences involved a prospective clinical trial that specifically investigated radiation oncology&#x02013;radiology collaboration as a treatment planning intervention for patients with locally advanced lung cancer: addition of a radiologist to the PR process resulted in changes in the tumor volume in over one-third of patients.<sup><xref rid="zoi241467r17" ref-type="bibr">17</xref></sup> Among patients with head and neck cancer, Gatfield et al<sup><xref rid="zoi241467r18" ref-type="bibr">18</xref></sup> prospectively compared PR outcomes with vs without radiology involvement and found that the presence of a neuroradiologist increased the rate of changes to delineated structures by two-thirds (from 33% to 55%). While changes to RT targets or OARs may increase with additional layers of PR, it is yet to be determined whether these changes result in different clinical outcomes. One study reporting head and neck RT PR identified a mean volumetric change in target volumes of 20% to 22%, with the upper range being greater than 100% to greater than 275%.<sup><xref rid="zoi241467r14" ref-type="bibr">14</xref></sup> These quantities represent substantial revisions to the RT targets and, in the era of highly conformal RT techniques, could be expected to impact the risk of locoregional failure.</p><p>The benefits of radiology involvement in PR of radiation oncologist&#x02013;delineated contours must outweigh the potential barriers to routine implementation of this practice. The main potential benefit apparent from our meta-analysis is clinically meaningful improvements to the RT plan. However, barriers include time limitations, technological considerations, and lack of a current reimbursement model for this additional effort. Radiation oncologists may worry that radiologist participation in PR could elicit additional time-consuming but less clinically meaningful minor changes, though the findings from our meta-analysis do not support an increase in minor change rates. Time constraints on both sides of the interdisciplinary spectrum must be considered: attending PR conferences or soliciting on-demand PR during busy clinical services is a major barrier. The most efficient PR method may vary by institution; the logistics of radiology&#x02013;radiation oncology PR may include in-person or virtual conferences, telephone conversations, asynchronous review of images via the electronic health record, or other methods of communication. Novel methods to facilitate interdisciplinary review of RT targets that improve the ease of use for the reviewing radiologist are needed. Farris et al<sup><xref rid="zoi241467r17" ref-type="bibr">17</xref></sup> developed a novel script-based framework for transferring the contoured images from the RT planning computed tomographic image set into an anonymized portable document format (PDF) that can then be shared with the reviewing radiologist. Development of automated systems integrated within the institutional picture archiving and communication systems may increase efficiency, improve implementation, and inform follow-up imaging interpretation.<sup><xref rid="zoi241467r47" ref-type="bibr">47</xref>,<xref rid="zoi241467r48" ref-type="bibr">48</xref></sup> However, without a reimbursement mechanism, radiologists&#x02019; time spent reviewing radiation oncologists&#x02019; targets ultimately detracts from their diagnostic productivity, which may require up to 30 to 60 minutes per case review, depending on the complexity.<sup><xref rid="zoi241467r17" ref-type="bibr">17</xref></sup> Considering the high cost of salvage or palliative therapies (such as immunotherapy) for patients with recurrence after RT and the high rates of clinically significant changes to the RT plan identified in our study, preventing failure through radiologist PR could represent a cost-effective intervention. Prospective evidence of improved oncologic outcomes would be necessary to support the development of professional reimbursement mechanisms or procedure codes like those used in other RT planning procedures, such as radiosurgery.</p><p>Our findings also provide practical insight into the efficient and cost-effective use of multidisciplinary resources for collaborative PR of RT targets. Subgroup analyses indicate that radiology incorporation into PR of head and neck and lung cancer treatment plans yields consistently high rates of change. We also observed significantly higher change rates to the RT plan when PR is performed before compared with after the RT plan has already been finalized. Since there was no difference in the rate of RT plan changes based on frequency of PR, the most flexible and feasible schedule that maximizes interdisciplinary participation can be used without the risk of affecting PR outcomes. A streamlined process for radiation oncology&#x02013;radiology collaboration may also increase the efficiency and quality of image interpretation after RT, as the details of RT location, distribution, and timing are often not readily available in the medical record.<sup><xref rid="zoi241467r49" ref-type="bibr">49</xref></sup></p><sec id="H2-5-ZOI241467"><title>Limitations</title><p>This study is limited by the study-level nature of the meta-analysis, the lack of studies reporting PR outcomes with and without radiologist involvement, the imbalance in total number of cases between groups, and the high heterogeneity of the included studies. Due to the small number of cases with radiology-based PR, these findings should be interpreted with caution. The fact that 0.6% of all identified cases (1.2% when excluding the 20&#x02009;069 cases reported in the largest nonradiology study by Tchelebi et al<sup><xref rid="zoi241467r10" ref-type="bibr">10</xref></sup>) reported radiology-based PR highlights the critical need for additional data in this space. Despite the ubiquity of PR in radiation oncology and routine collaboration between radiation oncology and radiology in the course of clinical care, limited data exist to measure the clinical impact of radiologist&#x02013;radiation oncologist collaboration in PR of contoured targets. Additional prospective investigations including multiple disease sites are necessary to better understand the clinical impact of incorporating radiologists in radiation oncology PR in an unbiased, unselected sample. While there are differences in sample size between groups, meta-analytic techniques, such as the random-effects models reported herein, are expected to minimize confounding. Regarding heterogeneity, while removal of outlier studies in the primary analyses of all changes, major changes, and minor changes reduced heterogeneity to a reasonable level (<italic>I</italic><sup>2</sup>&#x02009;&#x0003c;&#x02009;50%) in the radiologist group, heterogeneity remained high in the group without a radiologist. Since PR in radiation oncology is highly variable by nature, this heterogeneity is expected and suggests generalizability across multiple PR methods, timing, and formats. Additionally, removal of outliers did not substantially change the findings of these analyses. Because only 1 study reported outcomes of PR with and without radiologist involvement, comparisons within studies were not possible, so the findings of these comparisons between studies are subject to confounding. The inclusion of retrospective and prospective studies may also introduce bias, as a higher rate of changes was observed in prospective studies, as would be expected in quality improvement studies aimed at improving RT plans through prospective assessment of PR. Additional prospective study of this interdisciplinary collaboration can investigate the impact of radiology involvement directly on clinical outcomes, such as local disease control and survival.</p></sec></sec><sec id="H1-5-ZOI241467"><title>Conclusions</title><p>In this systematic review and meta-analysis of radiation oncology PR of contoured targets, radiologist involvement was associated with higher rates of clinically relevant changes to the RT target and total changes to the RT plan. Radiologist involvement was not associated with rates of minor RT plan changes. These results support the value of interdisciplinary collaboration with radiology during RT planning. Further efforts to maximize the efficiency and cost-effectiveness of closer interdisciplinary collaboration between these 2 specialties would be expected to increase the quality of RT and improve cancer outcomes, which warrants evaluation in prospective clinical trials.</p></sec></body><back><ref-list id="REF-ZOI241467"><title>References</title><ref id="zoi241467r1"><label>1</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Marks</surname>
<given-names>LB</given-names></string-name>, <string-name><surname>Adams</surname>
<given-names>RD</given-names></string-name>, <string-name><surname>Pawlicki</surname>
<given-names>T</given-names></string-name>, <etal/></person-group>. <article-title>Enhancing the role of case-oriented peer review to improve quality and safety in radiation oncology: executive summary</article-title>. <source>Pract Radiat Oncol</source>. <year>2013</year>;<volume>3</volume>(<issue>3</issue>):<fpage>149</fpage>-<lpage>156</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.prro.2012.11.010</pub-id>
<pub-id pub-id-type="pmid">24175002</pub-id>
</mixed-citation></ref><ref id="zoi241467r2"><label>2</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Lawrence</surname>
<given-names>YR</given-names></string-name>, <string-name><surname>Whiton</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Symon</surname>
<given-names>Z</given-names></string-name>, <etal/></person-group>. Quality assurance peer review chart rounds in 2011: a survey of academic institutions in the United States. <source>Int J Radiat Oncol Biol Phys</source>. <year>2012</year>;<volume>84</volume>(<issue>3</issue>):<fpage>590</fpage>-<lpage>595</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ijrobp.2012.01.029</pub-id><pub-id pub-id-type="pmid">22445006</pub-id>
</mixed-citation></ref><ref id="zoi241467r3"><label>3</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Martin-Garcia</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Celada-&#x000c1;lvarez</surname>
<given-names>F</given-names></string-name>, <string-name><surname>P&#x000e9;rez-Calatayud</surname>
<given-names>MJ</given-names></string-name>, <etal/></person-group>. <article-title>100% Peer review in radiation oncology: is it feasible?</article-title>
<source>Clin Transl Oncol</source>. <year>2020</year>;<volume>22</volume>(<issue>12</issue>):<fpage>2341</fpage>-<lpage>2349</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s12094-020-02394-8</pub-id>
<pub-id pub-id-type="pmid">32557395</pub-id>
</mixed-citation></ref><ref id="zoi241467r4"><label>4</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Reddeman</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Foxcroft</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Gutierrez</surname>
<given-names>E</given-names></string-name>, <etal/></person-group>. Improving the quality of radiation treatment for patients in Ontario: increasing peer review activities on a jurisdictional level using a change management approach. <source>J Oncol Pract</source>. <year>2016</year>;12(1):81-82, e61-e70. doi:<pub-id pub-id-type="doi">10.1200/JOP.2015.006882</pub-id></mixed-citation></ref><ref id="zoi241467r5"><label>5</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Talcott</surname>
<given-names>WJ</given-names></string-name>, <string-name><surname>Lincoln</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Kelly</surname>
<given-names>JR</given-names></string-name>, <etal/></person-group>. <article-title>A blinded, prospective study of error detection during physician chart rounds in radiation oncology</article-title>. <source>Pract Radiat Oncol</source>. <year>2020</year>;<volume>10</volume>(<issue>5</issue>):<fpage>312</fpage>-<lpage>320</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.prro.2020.05.012</pub-id>
<pub-id pub-id-type="pmid">32888524</pub-id>
</mixed-citation></ref><ref id="zoi241467r6"><label>6</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Cooper</surname>
<given-names>BT</given-names></string-name>, <string-name><surname>Goenka</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Sine</surname>
<given-names>K</given-names></string-name>, <etal/></person-group>. <article-title>Development of a comprehensive, contour-based, peer review workflow at a community proton center</article-title>. <source>Int J Part Ther</source>. <year>2020</year>;<volume>7</volume>(<issue>1</issue>):<fpage>34</fpage>-<lpage>40</lpage>. doi:<pub-id pub-id-type="doi">10.14338/IJPT-19-00059.1</pub-id>
<pub-id pub-id-type="pmid">33094134</pub-id>
</mixed-citation></ref><ref id="zoi241467r7"><label>7</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Khader</surname>
<given-names>JK</given-names></string-name>, <string-name><surname>Al-Mousa</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>Mohamad</surname>
<given-names>IA</given-names></string-name>, <etal/></person-group>. <article-title>Enhancing value of quality assurance rounds in improving radiotherapy management: a retrospective analysis from King Hussein Cancer Center in Jordan</article-title>. <source>Radiat Oncol J</source>. <year>2019</year>;<volume>37</volume>(<issue>1</issue>):<fpage>60</fpage>-<lpage>65</lpage>. doi:<pub-id pub-id-type="doi">10.3857/roj.2019.00080</pub-id>
<pub-id pub-id-type="pmid">30947482</pub-id>
</mixed-citation></ref><ref id="zoi241467r8"><label>8</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Brammer</surname>
<given-names>CV</given-names></string-name>, <string-name><surname>Pettit</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Allerton</surname>
<given-names>R</given-names></string-name>, <etal/></person-group>. <article-title>Impact of the introduction of weekly radiotherapy quality assurance meetings at one UK cancer centre</article-title>. <source>Br J Radiol</source>. <year>2014</year>;<volume>87</volume>(<issue>1043</issue>):<elocation-id>20140422</elocation-id>. doi:<pub-id pub-id-type="doi">10.1259/bjr.20140422</pub-id>
<pub-id pub-id-type="pmid">25251520</pub-id>
</mixed-citation></ref><ref id="zoi241467r9"><label>9</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Mitchell</surname>
<given-names>JD</given-names></string-name>, <string-name><surname>Chesnut</surname>
<given-names>TJ</given-names></string-name>, <string-name><surname>Eastham</surname>
<given-names>DV</given-names></string-name>, <string-name><surname>Demandante</surname>
<given-names>CN</given-names></string-name>, <string-name><surname>Hoopes</surname>
<given-names>DJ</given-names></string-name></person-group>. <article-title>Detailed prospective peer review in a community radiation oncology clinic</article-title>. <source>Pract Radiat Oncol</source>. <year>2017</year>;<volume>7</volume>(<issue>1</issue>):<fpage>50</fpage>-<lpage>56</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.prro.2016.08.011</pub-id>
<pub-id pub-id-type="pmid">27720701</pub-id>
</mixed-citation></ref><ref id="zoi241467r10"><label>10</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Tchelebi</surname>
<given-names>LT</given-names></string-name>, <string-name><surname>Kapur</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Chou</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Potters</surname>
<given-names>L</given-names></string-name></person-group>. <article-title>A decade of prospective peer review: impact on safety culture and lessons learned in a multicenter radiation medicine department</article-title>. <source>Pract Radiat Oncol</source>. <year>2023</year>;<volume>13</volume>(<issue>4</issue>):<fpage>e325</fpage>-<lpage>e331</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.prro.2023.01.003</pub-id>
<pub-id pub-id-type="pmid">36706911</pub-id>
</mixed-citation></ref><ref id="zoi241467r11"><label>11</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Qureshi</surname>
<given-names>BM</given-names></string-name>, <string-name><surname>Mansha</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Karim</surname>
<given-names>MU</given-names></string-name>, <etal/></person-group>. <article-title>Impact of peer review in the radiation treatment planning process: experience of a tertiary care university hospital in Pakistan</article-title>. <source>J Glob Oncol</source>. <year>2019</year>;<volume>5</volume>:<fpage>1</fpage>-<lpage>7</lpage>. doi:<pub-id pub-id-type="doi">10.1200/JGO.19.00039</pub-id>
<pub-id pub-id-type="pmid">31393752</pub-id>
</mixed-citation></ref><ref id="zoi241467r12"><label>12</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Matalon</surname>
<given-names>SA</given-names></string-name>, <string-name><surname>Howard</surname>
<given-names>SA</given-names></string-name>, <string-name><surname>Abrams</surname>
<given-names>MJ</given-names></string-name></person-group>. <article-title>Assessment of radiology training during radiation oncology residency</article-title>. <source>J Cancer Educ</source>. <year>2019</year>;<volume>34</volume>(<issue>4</issue>):<fpage>691</fpage>-<lpage>695</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s13187-018-1357-1</pub-id>
<pub-id pub-id-type="pmid">29623563</pub-id>
</mixed-citation></ref><ref id="zoi241467r13"><label>13</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Adjogatse</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Petkar</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Reis Ferreira</surname>
<given-names>M</given-names></string-name>, <etal/></person-group>. <article-title>The impact of interactive MRI-based radiologist review on radiotherapy target volume delineation in head and neck cancer</article-title>. <source>AJNR Am J Neuroradiol</source>. <year>2023</year>;<volume>44</volume>(<issue>2</issue>):<fpage>192</fpage>-<lpage>198</lpage>. doi:<pub-id pub-id-type="doi">10.3174/ajnr.A7773</pub-id>
<pub-id pub-id-type="pmid">36702503</pub-id>
</mixed-citation></ref><ref id="zoi241467r14"><label>14</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Braunstein</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Glastonbury</surname>
<given-names>CM</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Quivey</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Yom</surname>
<given-names>SS</given-names></string-name></person-group>. <article-title>Impact of neuroradiology-based peer review on head and neck radiotherapy target delineation</article-title>. <source>AJNR Am J Neuroradiol</source>. <year>2017</year>;<volume>38</volume>(<issue>1</issue>):<fpage>146</fpage>-<lpage>153</lpage>. doi:<pub-id pub-id-type="doi">10.3174/ajnr.A4963</pub-id>
<pub-id pub-id-type="pmid">27811130</pub-id>
</mixed-citation></ref><ref id="zoi241467r15"><label>15</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Chiu</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Hoskin</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Gupta</surname>
<given-names>A</given-names></string-name>, <etal/></person-group>. <article-title>The quantitative impact of joint peer review with a specialist radiologist in head and neck cancer radiotherapy planning</article-title>. <source>Br J Radiol</source>. <year>2022</year>;<volume>95</volume>(<issue>1130</issue>):<elocation-id>20211219</elocation-id>. doi:<pub-id pub-id-type="doi">10.1259/bjr.20211219</pub-id>
<pub-id pub-id-type="pmid">34918547</pub-id>
</mixed-citation></ref><ref id="zoi241467r16"><label>16</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Dimigen</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Vinod</surname>
<given-names>SK</given-names></string-name>, <string-name><surname>Lim</surname>
<given-names>K</given-names></string-name></person-group>. <article-title>Incorporating a radiologist in a radiation oncology department: a new model of care?</article-title>
<source>Clin Oncol (R Coll Radiol)</source>. <year>2014</year>;<volume>26</volume>(<issue>10</issue>):<fpage>630</fpage>-<lpage>635</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.clon.2014.04.030</pub-id>
<pub-id pub-id-type="pmid">24880572</pub-id>
</mixed-citation></ref><ref id="zoi241467r17"><label>17</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Farris</surname>
<given-names>MK</given-names></string-name>, <string-name><surname>Razavian</surname>
<given-names>NB</given-names></string-name>, <string-name><surname>Hughes</surname>
<given-names>RT</given-names></string-name>, <etal/></person-group>. <article-title>Bridging the communication gaps: a prospective single-arm pilot study testing the feasibility of interdisciplinary radiotherapy planning in locally advanced lung cancer</article-title>. <source>Acad Radiol</source>. <year>2023</year>;<volume>30</volume>(<issue>11</issue>):<fpage>2566</fpage>-<lpage>2573</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.acra.2023.01.019</pub-id>
<pub-id pub-id-type="pmid">36759296</pub-id>
</mixed-citation></ref><ref id="zoi241467r18"><label>18</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Gatfield</surname>
<given-names>ER</given-names></string-name>, <string-name><surname>Benson</surname>
<given-names>RJ</given-names></string-name>, <string-name><surname>Jadon</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Das</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Barnett</surname>
<given-names>GC</given-names></string-name></person-group>. <article-title>The impact of neuroradiology collaboration in head and neck cancer radiotherapy peer review</article-title>. <source>Br J Radiol</source>. <year>2023</year>;<volume>96</volume>(<issue>1143</issue>):<elocation-id>20210238</elocation-id>. doi:<pub-id pub-id-type="doi">10.1259/bjr.20210238</pub-id>
<pub-id pub-id-type="pmid">36350288</pub-id>
</mixed-citation></ref><ref id="zoi241467r19"><label>19</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Gillespie</surname>
<given-names>EF</given-names></string-name>, <string-name><surname>Panjwani</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Golden</surname>
<given-names>DW</given-names></string-name>, <etal/></person-group>. <article-title>Multi-institutional randomized trial testing the utility of an interactive three-dimensional contouring atlas among radiation oncology residents</article-title>. <source>Int J Radiat Oncol Biol Phys</source>. <year>2017</year>;<volume>98</volume>(<issue>3</issue>):<fpage>547</fpage>-<lpage>554</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ijrobp.2016.11.050</pub-id>
<pub-id pub-id-type="pmid">28262474</pub-id>
</mixed-citation></ref><ref id="zoi241467r20"><label>20</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Gr&#x000e9;goire</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Evans</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Le</surname>
<given-names>QT</given-names></string-name>, <etal/></person-group>. <article-title>Delineation of the primary tumour clinical target volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelines</article-title>. <source>Radiother Oncol</source>. <year>2018</year>;<volume>126</volume>(<issue>1</issue>):<fpage>3</fpage>-<lpage>24</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.radonc.2017.10.016</pub-id>
<pub-id pub-id-type="pmid">29180076</pub-id>
</mixed-citation></ref><ref id="zoi241467r21"><label>21</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Giraud</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Elles</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Helfre</surname>
<given-names>S</given-names></string-name>, <etal/></person-group>. <article-title>Conformal radiotherapy for lung cancer: different delineation of the gross tumor volume (GTV) by radiologists and radiation oncologists</article-title>. <source>Radiother Oncol</source>. <year>2002</year>;<volume>62</volume>(<issue>1</issue>):<fpage>27</fpage>-<lpage>36</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0167-8140(01)00444-3</pub-id>
<pub-id pub-id-type="pmid">11830310</pub-id>
</mixed-citation></ref><ref id="zoi241467r22"><label>22</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Page</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Moher</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Bossuyt</surname>
<given-names>PM</given-names></string-name>, <etal/></person-group>. <article-title>PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews</article-title>. <source>BMJ</source>. <year>2021</year>;<volume>372</volume>(<issue>160</issue>):<fpage>n160</fpage>. doi:<pub-id pub-id-type="doi">10.1136/bmj.n160</pub-id>
<pub-id pub-id-type="pmid">33781993</pub-id>
</mixed-citation></ref><ref id="zoi241467r23"><label>23</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Slim</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Nini</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Forestier</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Kwiatkowski</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Panis</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Chipponi</surname>
<given-names>J</given-names></string-name></person-group>. <article-title>Methodological index for non-randomized studies (minors): development and validation of a new instrument</article-title>. <source>ANZ J Surg</source>. <year>2003</year>;<volume>73</volume>(<issue>9</issue>):<fpage>712</fpage>-<lpage>716</lpage>. doi:<pub-id pub-id-type="doi">10.1046/j.1445-2197.2003.02748.x</pub-id>
<pub-id pub-id-type="pmid">12956787</pub-id>
</mixed-citation></ref><ref id="zoi241467r24"><label>24</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Egger</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Davey Smith</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Schneider</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Minder</surname>
<given-names>C</given-names></string-name></person-group>. <article-title>Bias in meta-analysis detected by a simple, graphical test</article-title>. <source>BMJ</source>. <year>1997</year>;<volume>315</volume>(<issue>7109</issue>):<fpage>629</fpage>-<lpage>634</lpage>. doi:<pub-id pub-id-type="doi">10.1136/bmj.315.7109.629</pub-id>
<pub-id pub-id-type="pmid">9310563</pub-id>
</mixed-citation></ref><ref id="zoi241467r25"><label>25</label><mixed-citation publication-type="webpage"><italic>R: A Language and Environment for Statistical Computing</italic>. R Foundation for Statistical Computing; <year>2022</year>. Accessed June 19, 2024. <ext-link xlink:href="https://www.R-project.org/" ext-link-type="uri">https://www.R-project.org/</ext-link></mixed-citation></ref><ref id="zoi241467r26"><label>26</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Viechtbauer</surname>
<given-names>W</given-names></string-name></person-group>. Conducting meta-analyses in R with the metafor package. <source>J Stat Software</source>. <year>2010</year>;36(3):1-48. doi:<pub-id pub-id-type="doi">10.18637/jss.v036.i03</pub-id>
</mixed-citation></ref><ref id="zoi241467r27"><label>27</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Zairis</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Margalit</surname>
<given-names>DN</given-names></string-name>, <string-name><surname>Royce</surname>
<given-names>TJ</given-names></string-name>, <string-name><surname>Powlis</surname>
<given-names>WD</given-names></string-name>, <string-name><surname>Tishler</surname>
<given-names>RB</given-names></string-name>, <string-name><surname>Schoenfeld</surname>
<given-names>JD</given-names></string-name></person-group>. <article-title>Prospective analysis of radiation oncology image and plan-driven peer review for head and neck cancer</article-title>. <source>Head Neck</source>. <year>2017</year>;<volume>39</volume>(<issue>8</issue>):<fpage>1603</fpage>-<lpage>1608</lpage>. doi:<pub-id pub-id-type="doi">10.1002/hed.24800</pub-id>
<pub-id pub-id-type="pmid">28513902</pub-id>
</mixed-citation></ref><ref id="zoi241467r28"><label>28</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Samuel</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Thomas</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Gilson</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Prestwich</surname>
<given-names>RJD</given-names></string-name></person-group>. <article-title>Quality assurance peer review for radiotherapy for haematological malignancies</article-title>. <source>Clin Oncol (R Coll Radiol)</source>. <year>2019</year>;<volume>31</volume>(<issue>10</issue>):<fpage>e1</fpage>-<lpage>e8</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.clon.2019.06.010</pub-id>
<pub-id pub-id-type="pmid">31296456</pub-id>
</mixed-citation></ref><ref id="zoi241467r29"><label>29</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Rooney</surname>
<given-names>KP</given-names></string-name>, <string-name><surname>McAleese</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Crockett</surname>
<given-names>C</given-names></string-name>, <etal/></person-group>. <article-title>The impact of colleague peer review on the radiotherapy treatment planning process in the radical treatment of lung cancer</article-title>. <source>Clin Oncol (R Coll Radiol)</source>. <year>2015</year>;<volume>27</volume>(<issue>9</issue>):<fpage>514</fpage>-<lpage>518</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.clon.2015.05.010</pub-id>
<pub-id pub-id-type="pmid">26150375</pub-id>
</mixed-citation></ref><ref id="zoi241467r30"><label>30</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Ramasamy</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Murray</surname>
<given-names>LJ</given-names></string-name>, <string-name><surname>Cardale</surname>
<given-names>K</given-names></string-name>, <etal/></person-group>. <article-title>Quality assurance peer review of head and neck contours in a large cancer centre via a weekly meeting approach</article-title>. <source>Clin Oncol (R Coll Radiol)</source>. <year>2019</year>;<volume>31</volume>(<issue>6</issue>):<fpage>344</fpage>-<lpage>351</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.clon.2019.03.001</pub-id>
<pub-id pub-id-type="pmid">30890299</pub-id>
</mixed-citation></ref><ref id="zoi241467r31"><label>31</label><mixed-citation publication-type="journal"><person-group><string-name><surname>McClelland</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Amy Achiko</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Bartlett</surname>
<given-names>GK</given-names></string-name>, <etal/></person-group>. <article-title>Analysis of virtual versus in-person prospective peer review workflow in a multisite academic radiation oncology department</article-title>. <source>Adv Radiat Oncol</source>. <year>2021</year>;<volume>6</volume>(<issue>6</issue>):<elocation-id>100766</elocation-id>. doi:<pub-id pub-id-type="doi">10.1016/j.adro.2021.100766</pub-id>
<pub-id pub-id-type="pmid">34585027</pub-id>
</mixed-citation></ref><ref id="zoi241467r32"><label>32</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Matuszak</surname>
<given-names>MM</given-names></string-name>, <string-name><surname>Hadley</surname>
<given-names>SW</given-names></string-name>, <string-name><surname>Feng</surname>
<given-names>M</given-names></string-name>, <etal/></person-group>. <article-title>Enhancing safety and quality through preplanning peer review for patients undergoing stereotactic body radiation therapy</article-title>. <source>Pract Radiat Oncol</source>. <year>2016</year>;<volume>6</volume>(<issue>2</issue>):<fpage>e39</fpage>-<lpage>e46</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.prro.2015.09.009</pub-id>
<pub-id pub-id-type="pmid">26746815</pub-id>
</mixed-citation></ref><ref id="zoi241467r33"><label>33</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Mackenzie</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Graham</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Olivotto</surname>
<given-names>IA</given-names></string-name></person-group>. <article-title>Peer review of radiotherapy planning: quantifying outcomes and a proposal for prospective data collection</article-title>. <source>Clin Oncol (R Coll Radiol)</source>. <year>2016</year>;<volume>28</volume>(<issue>12</issue>):<fpage>e192</fpage>-<lpage>e198</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.clon.2016.08.012</pub-id>
<pub-id pub-id-type="pmid">27633327</pub-id>
</mixed-citation></ref><ref id="zoi241467r34"><label>34</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Lymberiou</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Galuszka</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>G</given-names></string-name>, <etal/></person-group>. <article-title>Predictors of breast radiotherapy plan modifications: quality assurance rounds in a large cancer centre</article-title>. <source>Radiother Oncol</source>. <year>2015</year>;<volume>114</volume>(<issue>1</issue>):<fpage>17</fpage>-<lpage>21</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.radonc.2014.11.042</pub-id>
<pub-id pub-id-type="pmid">25483219</pub-id>
</mixed-citation></ref><ref id="zoi241467r35"><label>35</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Huo</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Morley</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Dawson</surname>
<given-names>L</given-names></string-name>, <etal/></person-group>. <article-title>Peer review quality assurance in stereotactic body radiotherapy planning: the impact of case volume</article-title>. <source>J Radiother Pract</source>. <year>2022</year>;<volume>22</volume>:<elocation-id>e46</elocation-id>. doi:<pub-id pub-id-type="doi">10.1017/S1460396922000152</pub-id>
</mixed-citation></ref><ref id="zoi241467r36"><label>36</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Hesse</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Yu</surname>
<given-names>Y</given-names></string-name>, <etal/></person-group>. <article-title>Peer review of head and neck cancer planning target volumes in radiation oncology</article-title>. <source>Adv Radiat Oncol</source>. <year>2022</year>;<volume>7</volume>(<issue>3</issue>):<elocation-id>100917</elocation-id>. doi:<pub-id pub-id-type="doi">10.1016/j.adro.2022.100917</pub-id>
<pub-id pub-id-type="pmid">35647395</pub-id>
</mixed-citation></ref><ref id="zoi241467r37"><label>37</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Gogineni</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Schaefer</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Ewing</surname>
<given-names>A</given-names></string-name>, <etal/></person-group>. <article-title>Systematic implementation of effective quality assurance processes for the assessment of radiation target volumes in head and neck cancer</article-title>. <source>Pract Radiat Oncol</source>. <year>2024</year>;<volume>14</volume>(<issue>3</issue>):<fpage>e205</fpage>-<lpage>e213</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.prro.2023.12.012</pub-id>
<pub-id pub-id-type="pmid">38237893</pub-id>
</mixed-citation></ref><ref id="zoi241467r38"><label>38</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Fong</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Sanghera</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Good</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Nightingale</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Hartley</surname>
<given-names>A</given-names></string-name></person-group>. <article-title>Implementing head and neck contouring peer review without pathway delay: the on-demand approach</article-title>. <source>Clin Oncol (R Coll Radiol)</source>. <year>2017</year>;<volume>29</volume>(<issue>12</issue>):<fpage>841</fpage>-<lpage>847</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.clon.2017.09.005</pub-id>
<pub-id pub-id-type="pmid">28988705</pub-id>
</mixed-citation></ref><ref id="zoi241467r39"><label>39</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Fitzgerald</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Pryor</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Aland</surname>
<given-names>T</given-names></string-name>, <etal/></person-group>. <article-title>Quality and access&#x02014;early experience of implementing a virtual stereotactic chart round across a national network</article-title>. <source>J Med Imaging Radiat Oncol</source>. <year>2020</year>;<volume>64</volume>(<issue>3</issue>):<fpage>422</fpage>-<lpage>426</lpage>. doi:<pub-id pub-id-type="doi">10.1111/1754-9485.13031</pub-id>
<pub-id pub-id-type="pmid">32329199</pub-id>
</mixed-citation></ref><ref id="zoi241467r40"><label>40</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Cardenas</surname>
<given-names>CE</given-names></string-name>, <string-name><surname>Mohamed</surname>
<given-names>ASR</given-names></string-name>, <string-name><surname>Tao</surname>
<given-names>R</given-names></string-name>, <etal/></person-group>. <article-title>Prospective qualitative and quantitative analysis of real-time peer review quality assurance rounds incorporating direct physical examination for head and neck cancer radiation therapy</article-title>. <source>Int J Radiat Oncol Biol Phys</source>. <year>2017</year>;<volume>98</volume>(<issue>3</issue>):<fpage>532</fpage>-<lpage>540</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ijrobp.2016.11.019</pub-id>
<pub-id pub-id-type="pmid">28258898</pub-id>
</mixed-citation></ref><ref id="zoi241467r41"><label>41</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Bhattacharyya</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Chakraborty</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Achari</surname>
<given-names>RB</given-names></string-name>, <etal/></person-group>. <article-title>Enhancing quality assurance in radiotherapy for gynaecological cancers: implementation of an on-demand peer review process</article-title>. <source>Br J Radiol</source>. <year>2024</year>;<volume>97</volume>(<issue>1155</issue>):<fpage>680</fpage>-<lpage>693</lpage>. doi:<pub-id pub-id-type="doi">10.1093/bjr/tqae019</pub-id>
<pub-id pub-id-type="pmid">38401533</pub-id>
</mixed-citation></ref><ref id="zoi241467r42"><label>42</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Ballo</surname>
<given-names>MT</given-names></string-name>, <string-name><surname>Chronowski</surname>
<given-names>GM</given-names></string-name>, <string-name><surname>Schlembach</surname>
<given-names>PJ</given-names></string-name>, <string-name><surname>Bloom</surname>
<given-names>ES</given-names></string-name>, <string-name><surname>Arzu</surname>
<given-names>IY</given-names></string-name>, <string-name><surname>Kuban</surname>
<given-names>DA</given-names></string-name></person-group>. <article-title>Prospective peer review quality assurance for outpatient radiation therapy</article-title>. <source>Pract Radiat Oncol</source>. <year>2014</year>;<volume>4</volume>(<issue>5</issue>):<fpage>279</fpage>-<lpage>284</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.prro.2013.11.004</pub-id>
<pub-id pub-id-type="pmid">25194094</pub-id>
</mixed-citation></ref><ref id="zoi241467r43"><label>43</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Ali</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Schreibmann</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Kayode</surname>
<given-names>O</given-names></string-name>, <etal/></person-group>. <article-title>Implementation of a novel chart rounds application to facilitate peer review in a virtual academic environment</article-title>. <source>Adv Radiat Oncol</source>. <year>2023</year>;<volume>9</volume>(<issue>3</issue>):<elocation-id>101406</elocation-id>. doi:<pub-id pub-id-type="doi">10.1016/j.adro.2023.101406</pub-id>
<pub-id pub-id-type="pmid">38298329</pub-id>
</mixed-citation></ref><ref id="zoi241467r44"><label>44</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Farris</surname>
<given-names>JC</given-names></string-name>, <string-name><surname>Razavian</surname>
<given-names>NB</given-names></string-name>, <string-name><surname>Farris</surname>
<given-names>MK</given-names></string-name>, <etal/></person-group>. Head and neck radiotherapy quality assurance conference for dedicated review of delineated targets and organs at risk: results of a prospective study. <source>J Radiother Pract</source>. <year>2022</year>;22:e60. doi:<pub-id pub-id-type="doi">10.1017/s1460396922000309</pub-id>
</mixed-citation></ref><ref id="zoi241467r45"><label>45</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Fairchild</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Straube</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Laurie</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Followill</surname>
<given-names>D</given-names></string-name></person-group>. Does quality of radiation therapy predict outcomes of multicenter cooperative group trials? a literature review. <source>Int J Radiat Oncol Biol Phys</source>. <year>2013</year>;87(2):246-260. doi:<pub-id pub-id-type="doi">10.1016/j.ijrobp.2013.03.036</pub-id>
</mixed-citation></ref><ref id="zoi241467r46"><label>46</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Ohri</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Shen</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Dicker</surname>
<given-names>AP</given-names></string-name>, <string-name><surname>Doyle</surname>
<given-names>LA</given-names></string-name>, <string-name><surname>Harrison</surname>
<given-names>AS</given-names></string-name>, <string-name><surname>Showalter</surname>
<given-names>TN</given-names></string-name></person-group>. <article-title>Radiotherapy protocol deviations and clinical outcomes: a meta-analysis of cooperative group clinical trials</article-title>. <source>J Natl Cancer Inst</source>. <year>2013</year>;<volume>105</volume>(<issue>6</issue>):<fpage>387</fpage>-<lpage>393</lpage>. doi:<pub-id pub-id-type="doi">10.1093/jnci/djt001</pub-id>
<pub-id pub-id-type="pmid">23468460</pub-id>
</mixed-citation></ref><ref id="zoi241467r47"><label>47</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Savjani</surname>
<given-names>RR</given-names></string-name>, <string-name><surname>Salamon</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Deng</surname>
<given-names>J</given-names></string-name>, <etal/></person-group>. <article-title>A framework for sharing radiation dose distribution maps in the electronic medical record for improving multidisciplinary patient management</article-title>. <source>Radiol Imaging Cancer</source>. <year>2021</year>;<volume>3</volume>(<issue>2</issue>):<elocation-id>e200075</elocation-id>. doi:<pub-id pub-id-type="doi">10.1148/rycan.2021200075</pub-id>
<pub-id pub-id-type="pmid">33817649</pub-id>
</mixed-citation></ref><ref id="zoi241467r48"><label>48</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Hutten</surname>
<given-names>RJ</given-names></string-name>, <string-name><surname>Nelson</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Sarkar</surname>
<given-names>V</given-names></string-name>, <etal/></person-group>. <article-title>Feasibility and clinical utility of a workflow interfacing radiation oncology lung stereotactic body radiation therapy treatment planning and diagnostic radiology</article-title>. <source>Pract Radiat Oncol</source>. <year>2022</year>;<volume>12</volume>(<issue>6</issue>):<fpage>e512</fpage>-<lpage>e516</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.prro.2022.06.007</pub-id>
<pub-id pub-id-type="pmid">35752410</pub-id>
</mixed-citation></ref><ref id="zoi241467r49"><label>49</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Schaub</surname>
<given-names>SK</given-names></string-name>, <string-name><surname>Ermoian</surname>
<given-names>RP</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>CL</given-names></string-name>, <etal/></person-group>. <article-title>Bridging the radiation oncology and diagnostic radiology communication gap: a survey to determine usefulness and optimal presentation of radiotherapy treatment plans for radiologists</article-title>. <source>Curr Probl Diagn Radiol</source>. <year>2020</year>;<volume>49</volume>(<issue>3</issue>):<fpage>161</fpage>-<lpage>167</lpage>. doi:<pub-id pub-id-type="doi">10.1067/j.cpradiol.2019.02.009</pub-id>
<pub-id pub-id-type="pmid">30885420</pub-id>
</mixed-citation></ref></ref-list><notes notes-type="supplementary-material" id="note-ZOI241467-1"><supplementary-material id="note-ZOI241467-1-s" position="float" content-type="local-data"><label>Supplement 1.</label><caption><p><bold>eMethods.</bold> Search Strategy</p><p><bold>eFigure 1.</bold> PRISMA Flow Diagram</p><p><bold>eFigure 2.</bold> Funnel Plot for Publication Bias of RT Plan Changes Based on Sample Size in All Included Studies</p><p><bold>eFigure 3.</bold> Forest Plot and Pooled Rates of Changes to Organs at Risk by Radiology Involvement</p><p><bold>eFigure 4.</bold> Forest Plot and Pooled Estimates of Changes to the Radiotherapy Plan as a Result of Peer Review</p><p><bold>eFigure 5.</bold> Forest Plot and Pooled Estimates of Recommendations for Changes to the Radiotherapy Plan as a Result of Peer Review</p><p><bold>eFigure 6.</bold> Forest Plot and Pooled Estimates of Plan Changes and Recommendations for Change</p><p><bold>eFigure 7.</bold> Forest Plot and Pooled Estimates of Plan Changes Based on Cancer Site</p><p><bold>eFigure 8.</bold> Forest Plot and Pooled Estimates of Plan Changes Based on Timing of Peer Review Related to the RT Planning Process</p><p><bold>eFigure 9.</bold> Forest Plot and Pooled Estimates of Plan Changes Based on Frequency of Peer Review Meetings</p><p><bold>eFigure 10.</bold> Forest Plot and Pooled Estimates of Plan Changes in Prospective vs Retrospective Studies</p><p><bold>eFigure 11.</bold> Forest Plot and Pooled Estimates of Plan Changes by Radiology Involvement in a Subgroup Analysis of Only Prospective Studies</p><p><bold>eFigure 12.</bold> Forest Plot and Pooled Estimates of Plan Changes Based on Radiology Involvement in a Subgroup Analysis of Only Retrospective Studies</p><p><bold>eTable 1.</bold> Characteristics of Included Studies</p><p><bold>eTable 2.</bold> Intent of Treatment</p><p><bold>eTable 3.</bold> Quality of Included Studies Assessed by the MINORS Criteria</p></caption><media xlink:href="jamanetwopen-e2452667-s001.pdf"/></supplementary-material><supplementary-material position="float" content-type="local-data"><label>Supplement 2.</label><caption><p>
Data Sharing Statement
</p></caption><media xlink:href="jamanetwopen-e2452667-s002.pdf"/></supplementary-material></notes></back></article><!--requester-ID dobrandt-->